GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                                     
                             Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Cl-amidine is an inhihbitor of protein arginine deiminases (PADIs). Although reported to preferentially inhibit PADI1, isozyme selectivity is poor [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| The authors provide inhibition values as rate constants (kinact/KI) for Cl-amidine as a measure of inhibitory activity. The rate constants for PADI1 and PADI2 are 4.55x103 M-1 min-1 and 5.2x102 M-1 min-1 respectively. NB click on the down arrow at the end of the row in the table below to reveal the rate constant.  | 
                                                        
| Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
                                                                        
                                                                         
  | 
                                                                |||||||||||||||||||||||||||||||||||||||||||||||||||||||